Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells
Uchini S. Kosgodage(London Metropolitan University), Sigrun Lange(University College London), Alistair V.W. Nunn(University of Westminster), Pinar Uysal‐Onganer(NIHR Imperial Biomedical Research Centre), Jameel M. Inal(London Metropolitan University), Rhys R. Mould(University of Westminster), Jimmy D. Bell(Imperial College London), Amy MacLatchy(University of Westminster), E. Louise Thomas(Hammersmith Hospital), Geoffrey W. Guy(GW Pharmaceuticals (United Kingdom)), Nicholas P. Chatterton(The Open University), Igor Kraev(The Open University)
Cited by 57
Related Papers
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
|Nature Communications|2014|1.7k
Critical role for peptide YY in protein-mediated satiation and body-weight regulation
|Cell Metabolism|2006|623
Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-γ
|Diabetes|2003|429
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
|Molecular Cancer|2010|176
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
|Frontiers in Pharmacology|2018|145